ABC | Volume 114, Nº5, Maio 2020

Arq Bras Cardiol. 2020; 114(5):943-987 Diretrizes Diretriz Brasileira de Reabilitação Cardiovascular – 2020 278. Sorajja P, Nishimura RA, Gersh BJ, Dearani JA, Hodge DO, Wiste HJ, et al. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. J Am Coll Cardiol. 2009;54(3):234-41. 279. Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, et al. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2016;67(12):1399-409. 280. Dias KA, Link MS, Levine BD. Exercise Training for Patients With Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2018;72(10):1157-65. 281. Sorajja P, Allison T, Hayes C, Nishimura RA, Lam CS, Ommen SR. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2012;109(10):1494-8. 282. Maragiannis D, Alvarez PA, GhosnMG, Chin K, Hinojosa JJ, Buergler JM, et al. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance. Int J Cardiovasc Imaging. 2018;34(1):121-9. 283. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273-80. 284. Hindieh W, Adler A, Weissler-Snir A, Fourey D, Harris S, Rakowski H. Exercise in patients with hypertrophic cardiomyopathy: A review of current evidence, national guideline recommendations and a proposal for a new direction to fitness. J Sci Med Sport. 2017;20(4):333-8. 285. Sheikh N, Papadakis M, Schnell F, Panoulas V, Malhotra A, Wilson M, et al. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2015;8(7):e003454. 286. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324(5):295-301. 287. Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of Exercise Testing in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(11):1374-86. 288. Sasanuma N, Takahashi K, Yamauchi S, Itani Y, Tanaka T, Mabuchi S, et al. A five-year follow-up of a patient with fulminant myocarditis who underwent a stepwise and goal-oriented individualized comprehensive cardiac rehabilitation program. J Cardiol Cases. 2015;11(6):160-3. 289. Milani M. Exame em destaque: Teste Cardiopulmonar. Jornal do DERC. 2019;1(5):9. 290. Yanagi H, Shindo N. Effects of exercise therapy on polymyositis complicated by post-myocarditis cardiomyopathy: A case report. J Rehabil Med. 2017;49(3):282-5. 291. CorradoD, BassoC, JudgeDP. Arrhythmogenic Cardiomyopathy. Circ Res. 2017;121(7):784-802. 292. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 2006;114(17):1799-806. 293. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290-7. 294. Wang W, Orgeron G, Tichnell C, Murray B, Crosson J, Monfredi O, et al. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Heart Assoc. 2018;7(12).pii e008843. 295. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015;386(9995):813-25. 296. Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J. 2017;38(46):3449-60. 297. Hotta VT, Tendolo SC, Rodrigues ACT, Fernandes F, Nastari L, Mady C. Limitations in the Diagnosis of Noncompaction Cardiomyopathy by Echocardiography. Arq Bras Cardiol. 2017;109(5):483-8. 298. Thavendiranathan P, Dahiya A, PhelanD, Desai MY, TangWH. Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management. Heart. 2013;99(10):681-9. 299. Ganga HV, Thompson PD. Sports participation in non-compaction card iomyopathy:asystematicreview.BrJSportsMed. 2014;48(20):1466-71. 300. Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non- compaction in athletes? Heart. 2013;99(6):401-8. 301. Caselli S, Ferreira D, Kanawati E, Di Paolo F, Pisicchio C, Attenhofer Jost C, et al. Prominent left ventricular trabeculations in competitive athletes: A proposal for risk stratification and management. Int J Cardiol. 2016;223:590-5. 302. Tarasoutchi F, Montera MW, Grinberg M, Pineiro DJ, Sanchez CR, Bacelar AC, et al. Diretriz Brasileira de Valvopatias - SBC 2011/ I Diretriz Interamericana de Valvopatias - SIAC 2011. Arq Bras Cardiol. 2011;97(5 Suppl 1):1-67. 303. Baumgartner H, Falk V, Bax JJ, De Bonis M, HammC, HolmPJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91. 304. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin J 3rd, Guyton RA, et al. 2014 AHA/ACCGuideline for theManagement of PatientsWith Valvular Heart Disease: executive summary: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440-92. 305. Sibilitz KL, Berg SK, Tang LH, Risom SS, Gluud C, Lindschou J, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2016;3:CD010876. 306. Sibilitz KL, Berg SK, Rasmussen TB, Risom SS, Thygesen LC, Tang L, et al. Cardiac rehabilitation increases physical capacity but not mental health after heart valve surgery: a randomised clinical trial. Heart. 2016;102(24):1995-2003. 307. Lund K, Sibilitz KL, Berg SK, Thygesen LC, Taylor RS, Zwisler AD. Physical activity increases survival after heart valve surgery. Heart. 2016;102(17):1388-95. 308. Tamuleviciute-Prasciene E, Drulyte K, Jurenaite G, Kubilius R, Bjarnason- Wehrens B. Frailty and Exercise Training: How to Provide Best Care after Cardiac Surgery or Intervention for Elder Patients with Valvular Heart Disease. Biomed Res Int. 2018;2018:9849475. 309. Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, et al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta- analysis. Eur Heart J Qual Care Clin Outcomes. 2017;3(2):123-32. 310. Kehler DS, Stammers AN, Tangri N, Hiebert B, Fransoo R, Schultz ASH, et al. Systematic review of preoperative physical activity and its impact on postcardiac surgical outcomes. BMJ Open. 2017;7(8):e015712. 311. DeLarochelliere H, Urena M, Amat-Santos IJ, Ribeiro HB, Allende R, Laflamme L, et al. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015;115(4):472-9. 312. Lacombe SP, LaHaye SA, Hopkins-Rosseel D, Ball D, Lau W. Identifying patients at low risk for activity-related events: the RARE Score. J Cardiopulm Rehabil Prev. 2014;34(3):180-7. 985